Page last updated: 2024-08-23

amikacin and Empyema, Thoracic

amikacin has been researched along with Empyema, Thoracic in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Chen, SM; Chen, TT; Liu, HY1
Matsumoto, T; Otsuka, K; Tomii, K1

Other Studies

2 other study(ies) available for amikacin and Empyema, Thoracic

ArticleYear
Ceftazidime-avibactam and intrapleural amikacin therapy for extensively drug-resistant Pseudomonas aeruginosa thoracic empyema: A case report.
    Medicine, 2022, Jun-17, Volume: 101, Issue:24

    Topics: Amikacin; Anti-Bacterial Agents; Azabicyclo Compounds; Ceftazidime; Drug Combinations; Empyema, Pleural; Female; Humans; Microbial Sensitivity Tests; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections

2022
Mycobacterium fortuitum thoracic empyema: A case report and review of the literature.
    Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2015, Volume: 21, Issue:10

    Topics: Amikacin; Anti-Bacterial Agents; Chronic Disease; Cilastatin; Cilastatin, Imipenem Drug Combination; Clarithromycin; Drug Combinations; Drug Therapy, Combination; Empyema, Pleural; Humans; Hypercapnia; Imipenem; Male; Middle Aged; Mycobacterium fortuitum; Noninvasive Ventilation; Sulfamethoxazole

2015